Global Transplant Diagnostics Market Size is valued at USD 4.9 Bn in 2024 and is predicted to reach USD 10.4 Bn by the year 2034 at a 7.9% CAGR during the forecast period for 2025-2034.
The rise in organ transplants is a significant aspect driving demand for diagnostics utilized before surgery. There has always been a greater need for transplants than available organs. Nonetheless, the market will likely profit from in-depth field study and analysis to close this gap. The European Commission's initiatives for organ harvesting have made donated organs available.
The availability of the European donor card and rising public awareness have further increased the region's organ donation rate. Similar to other countries, the U.S. has seen significant organ donation increases due to increased awareness. Also, the demand for organ transplant surgeries is increasing due to the rising number of patients with chronic illnesses that frequently cause organ failure. Personalized medicine and stem cell therapy are also becoming more widely used. Pre-procedure diagnostics are in high demand as a result. Improved and sophisticated diagnostic methods are required due to the risks and complexity of organ transplantation.
Some of the primary Transplant Diagnostics Market players are:
The Transplant Diagnostics market is segmented on the basis of product & service, application, technology, transplant type, and end-user. Based on technology, the market is segmented into molecular assay technologies, sequencing-based molecular assays, and nonmolecular assay technologies. The product & service segment includes consumables, instruments, and software & services. By application, the market is segmented into diagnostic applications and research applications. By transplant type, the market is segmented as solid organ, stem cell, soft tissue, and bone marrow transplantation. End-use segment includes hospitals & Transplant services, research & academic institutes, and independent reference laboratories.
Reagents and consumables are anticipated to expand first, followed by the services and software category. The introduction of more complex instruments has raised the need for training sessions to instruct technical employees on handling and usage, which has contributed to the expansion of this market. Also, the industry growth is being fueled by elements like regular software upgrades and better services provided by market competitors to remain competitive.
The producers of these diagnostic products are using tactics like purchasing agreements for reagents and consumables. Moreover, the frequent procurement of reagents and consumables is a crucial element in speeding adoption. As a result, the category had the highest revenue share in 2016 and is anticipated to continue to hold the top spot throughout the projected period.
The majority of revenue came from North America. Key influences include the widespread use of cutting-edge methods and diagnostic technologies, rising healthcare costs, and the accessibility of qualified personnel. Due to factors including a highly established healthcare infrastructure and the availability of qualified specialists, the U.S. has the most significant market share. Also, the widespread use of stem cell therapies, tailored pharmaceuticals, and soft tissue transplants is promoting regional market expansion.
| Report Attribute | Specifications |
| Market size value in 2024 | USD 4.9 Bn |
| Revenue forecast in 2034 | USD 10.4 Bn |
| Growth rate CAGR | CAGR of 7.9% from 2025 to 2034 |
| Quantitative units | Representation of revenue in US$ Bn, and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
| Segments covered | Product & Service, Application, Technology, Transplant Type, And End-User. |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | BioMerieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific, Bio-Rad Laboratories, Bruker, and Merck KGaA. |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Transplant Diagnostics Market Snapshot
Chapter 4. Global Transplant Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Technology Estimates & Trend Analysis
5.1. by Technology & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology:
5.2.1. Molecular assay technologies
5.2.1.1. PCR-based molecular assays
5.2.1.2. Real-time PCR
5.2.1.3. Sequence-specific primer-PCR
5.2.1.4. Sequence-specific Oligonucleotide-PCR
5.2.1.5. Other PCR-based molecular assays
5.2.2. Sequencing based molecular assays
5.2.2.1. Sanger sequencing
5.2.2.2. Next generation sequencing
5.2.2.3. Other sequencing based molecular assays
5.2.3. Non molecular assays technologies
Chapter 6. Market Segmentation 2: by Product & Service Estimates & Trend Analysis
6.1. by Product & Service & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product & Service:
6.2.1. Reagents & Consumables
6.2.2. Instruments
6.2.3. Software & Services
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
7.2.1. Diagnostic Application
7.2.1.1. Pre-Transplantation Diagnostics
7.2.1.1.1. Infectious Disease Testing
7.2.1.1.2. Histocompatibility Testing
7.2.1.1.3. Blood Profiling
7.2.1.2. Post -Transplantation Diagnostics
7.2.2. Research Applications
Chapter 8. Market Segmentation 4: by Transplant Type Estimates & Trend Analysis
8.1. by Transplant Type & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Transplant Type:
8.2.1. Solid Organ Transplantation
8.2.1.1. Kidney Transplantation
8.2.1.2. Liver Transplantation
8.2.1.3. Heart Transplantation
8.2.1.4. Lung Transplantation
8.2.1.5. Pancreases Transplantation
8.2.1.6. Other Organs Transplantation
8.2.2. Stem Cell Transplantation
8.2.3. Soft Tissue Transplantation
8.2.4. Bone Marrow Transplantation
Chapter 9. Market Segmentation 5: by End-user Estimates & Trend Analysis
9.1. by End-user & Market Share, 2024 & 2034
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
9.2.1. Hospitals and Transplant centers
9.2.2. Research &Academic Institutes
9.2.3. Independent reference laboratories
Chapter 10. Transplant Diagnostics Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
10.1.2. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2021-2034
10.1.3. North America Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.1.4. North America Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.1.5. North America Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.1.6. North America Transplant Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.2. Europe
10.2.1. Europe Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.2.2. Europe Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.2.3. Europe Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.2.4. Europe Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.2.5. Europe Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.2.6. Europe Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.3. Asia Pacific
10.3.1. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.3.2. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.3.3. Asia-Pacific Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.3.4. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.3.5. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.3.6. Asia Pacific Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.4. Latin America
10.4.1. Latin America Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.4.2. Latin America Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.4.3. Latin America Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.4.4. Latin America Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.4.5. Latin America Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.4.6. Latin America Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
10.5. Middle East & Africa
10.5.1. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Technology, 2021-2034
10.5.2. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Product & Service, 2021-2034
10.5.3. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Application, 2021-2034
10.5.4. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by Transplant Type, 2021-2034
10.5.5. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by End-user, 2021-2034
10.5.6. Middle East & Africa Transplant Diagnostics Market revenue (US$ Million) by country, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Abbott Laboratories, Inc.
11.2.2. Adaptive Biotechnologies
11.2.3. Affymetrix, Inc.
11.2.4. altona Diagnostics GmbH
11.2.5. Arquer Diagnostics Ltd
11.2.6. BAG Diagnostics GmbH
11.2.7. Becton, Dickinson and Company,
11.2.8. Biofortuna Limited
11.2.9. BioMerieux SA,
11.2.10. Bio-rad Laboratories, Inc.
11.2.11. Biotype GmbH
11.2.12. Bruker,
11.2.13. CareDx Inc.
11.2.14. CLONIT srl
11.2.15. Diagnóstica Longwood SL
11.2.16. DiaSorin S.p.A.
11.2.17. ELITechGroup
11.2.18. EUROFINS VIRACOR
11.2.19. F. Hoffmann La-Roche AG.
11.2.20. Hologic, Inc.
11.2.21. Horiba Ltd
11.2.22. Illumina, Inc.
11.2.23. Immucor Transplant Diagnostics, Inc.
11.2.24. Laboratory Corporation of America Holdings.
11.2.25. Linkage Biosciences
11.2.26. Luminex Corporation
11.2.27. Merck KGaA
11.2.28. NanoString
11.2.29. Olerup SSP AB
11.2.30. Omixon Ltd.
11.2.31. PathoNostics
11.2.32. Preservation Solutions, Inc.
11.2.33. Qiagen N.V.
11.2.34. Randox Laboratories Ltd.
11.2.35. Stryker
11.2.36. Takara Bio Inc.
11.2.37. Thermo Fisher Scientific,
11.2.38. TransMedics
11.2.39. Transonic
11.2.40. Zimmer Biomet
11.2.41. Other Prominent Players
Transplant Diagnostics Market By Technology-
Transplant Diagnostics Market By Product & Service-
Transplant Diagnostics Market By Application-
Transplant Diagnostics Market By Transplant Type-
Transplant Diagnostics Market By End-User-
Transplant Diagnostics Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-